Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.

The Danbury Health and Human Services team is collaborating with the Norwalk Health Department to promote three significant ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

The company is advancing towards a pivotal phase in its vaccine development pipeline, targeting the initiation of Phase 3 trials for its influenza candidates. Additionally, Novavax is committed to ...

Contents What’s coming up in the remaining episodes of From season 3? Is there a trailer for From season 3? Has From season 3 begun filming? What will happen in From season 3? Who is in From’s ...

Hence, investors anticipating a more robust stock repurchase program could be disappointed, even though it still has $3.3B remaining in its authorization. I assess the company's capital allocation ...

Please turn to Slide 3. Today's call will last approximately ... 7% led by another outstanding performance from Trelegy. Total vaccine sales were down due to lower sales of Arexvy and Shingrix.

The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in ...

Two new COVID-19 vaccines targeting the KP. 2 variant of the virus have been made available for all Ontarians starting Monday, after weeks of only being open to high-risk and priority populations.

Dendrimeric designs for other FMDV serotypes and subtypes need to be developed and tested, but this new technology provides substantial promise for peptide-subunit vaccine development.